-
Article
Open AccessFive-year follow-up of the OptiTrain trial on concurrent resistance and high-intensity interval training during chemotherapy for patients with breast cancer
The protocol predefined aim of this study is to assess sustained effects of the OptiTrain trial on several health outcomes, 5 years after the baseline assessment. The OptiTrain study was a prospective, randomi...
-
Article
Open AccessBlood flow restriction Exercise in the perioperative setting to Prevent loss of muscle mass in patients with pancreatic, biliary tract, and liver cancer: study protocol for the PREV-Ex randomized controlled trial
Patients diagnosed with pancreatic, biliary tract, and liver cancer often suffer from a progressive loss of muscle mass. Given the considerable functional impairments in these patients, high musculoskeletal we...
-
Article
Open AccessThe weight loss grading system as a predictor of cancer cachexia in oesophageal cancer survivors
Oesophageal cancer survivorship is afflicted by cancer cachexia related weight loss and nutrition impact symptoms. Identifying the factors which predict cancer cachexia specifically is warranted in order to id...
-
Article
Role of dietitian support in improving weight loss and nutrition impact symptoms after oesophageal cancer surgery
Oesophageal cancer is frequently accompanied with malnutrition. We aimed to evaluate if early support from dietitians and patient’s level of satisfaction with the support from dietitians are associated with be...
-
Article
Open AccessCultural adaptation and psychometric evaluation of the Swedish version of the Reproductive Concerns After Cancer (RCAC) scale
Reproductive concerns are common among young cancer survivors and include worries related to different aspects of fertility and parenthood. The Reproductive Concerns After Cancer (RCAC) scale is an 18-item sca...
-
Article
Perioperative nutritional intervention: a way to improve long-term outcomes
-
Article
Cachexia in patients with oesophageal cancer
Weight loss, owing to malnutrition is common in patients with oesophageal cancer and is often associated with worse clinical outcomes